HBV: Clinical Trials

11 trials for HBV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 unknown, 2 terminated, 1 enrolling by invitation. 11 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 3, Unknown 3, Terminated 2, Enrolling by invitation 1, Recruiting 1, Withdrawn 1

Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study
Hepatect CP 50 I.E./ml infusion solution - Hepatocellular Carcinoma, HBV
Not applicableUnknownMedical University of Graz52024-11-012024-01-18
Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong
Wellnuts app intervention, Web-based health resources - Diabetes Risk, CVD Risk
Not applicableRecruitingThe University of Hong Kong5742024-06-012026-07-22
The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)
TRI-MOM intervention - Hiv, Syphilis
Not applicableUnknownInstitut de Recherche pour le Developpement28002024-03-182024-06-20
Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation
Baracle Tab.® - Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation
Not applicableEnrolling by invitationSeoul St. Mary's Hospital2262021-08-212025-07-18
HCV, HBV, HIV Testing During Consultation With Anesthesiologist
HCV, HBV, HIV tests - HCV, HBV
Not applicableTerminatedAssistance Publique - Hôpitaux de Paris3632021-08-052021-12-02
Tenofovir Alafenamide for HBV Prophylaxis in HBV(-) Liver Transplant Recipients With HBcAb+ Donors
Tenofovir Alafenamide 25 MG - HBV, Liver Transplant Disorder
Not applicableUnknownRenJi Hospital302021-04-012021-01-11
Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies
o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B - HBV
Not applicableCompletedCentre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida602020-09-152024-02-02
Prevention for Mother-to-infant Transmission of HBV
Hepatitis B immunoglobulin - HBV
Not applicableCompletedXi'an Jiaotong University282012-05-012014-12-09
Impact of Hepatitis B Vaccination on HBs Antigenemia
HBV vaccine - HBV
Not applicableCompletedZagazig University2202011-08-012017-06-21
Ultrasound Method to Measure Fibrosis of the Liver in Children
Shear Wave sonoelastography - Chronic Liver Disease, Non-Alcoholic Fatty Liver Disease
Not applicableTerminatedMassachusetts General Hospital242010-06-012017-02-01
'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT
Tenofovir + Interferon alpha 2b, Tenofovir disoproxil Fumarate - HBV
Not applicableWithdrawnInstitute of Liver and Biliary Sciences, India2018-02-08

Narrower conditions

Acquired Immunodeficiency Syndrome (2)  ·  Carcinoma, Hepatocellular (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Chronic Disease (1)  ·  Colorectal Neoplasms (1)  ·  Fibrosis (1)  ·  Hepatitis B (1)  ·  Lung Neoplasms (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Syphilis (1)

Broader conditions

Digestive System Diseases (4)  ·  Liver Diseases (3)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Genital Diseases (2)  ·  HIV Infections (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Lentivirus Infections (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

HIV Testing (1)  ·  Interferon alpha-2 (1)  ·  Rituximab (1)  ·  Tenofovir (1)  ·  hepatitis B hyperimmune globulin (1)  ·  ocrelizumab (1)  ·  tenofovir alafenamide (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida (1)  ·  Institut de Recherche pour le Developpement (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  Massachusetts General Hospital (1)  ·  Medical University of Graz (1)  ·  RenJi Hospital (1)  ·  Seoul St. Mary's Hospital (1)  ·  The University of Hong Kong (1)  ·  Xi'an Jiaotong University (1)  ·  Zagazig University (1)

Countries

France (2)  ·  Burkina Faso (1)  ·  Hong Kong (1)  ·  India (1)  ·  South Korea (1)  ·  The Gambia (1)  ·  United States (1)

Top investigators

Jeong Won Jang, Professor (1)  ·  Qiang Xia, MD., Ph.D. (1)  ·  Sylvie Boyer, PhD (1)  ·  Tianyan Chen, MD (1)  ·  Uzma Shah, MD, FAAP (1)  ·  William Chi Wai Wong, MD (1)  ·  Zhifeng Xi, MD. (1)

Results publications

PMID 26503488, PMID 28802168, PMID 41649980